Information about Canadian-Internet-Drugs.com
List of countries where we can ship Rotigotine:
Latest news releases on Rotigotine:
History. Rotigotine was first developed in 1985 as N-0437 by a team from the University of Groningen. Development was then continued by Aderis Pharmaceuticals.
Physician reviewed rotigotine (transdermal) (transdermal) patient information - includes rotigotine (transdermal) description, dosage and directions.
Easy-to-read patient leaflet for Rotigotine. Includes indications, proper use, special instructions, precautions, and possible side effects.
Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for ROTIGOTINE.
NEUPRO : Neupro est indiqué en monothérapie (sans lévodopa) pour le traitement des signes et symptômes du stade précoce de la maladie de Parkinson idiopathique ...
NEUPRO is a prescription medicine used to treat Parkinson's disease and moderate-to-severe primary restless leg syndrome. View Important Safety Information.
1 Neupro® 2 (Rotigotine Transdermal System) 3 CONTINUOUS DELIVERY FOR ONCE-DAILY APPLICATION 4 Rx Only 5 DESCRIPTION 6 Neupro® (Rotigotine Transdermal System) is a ...
Because rotigotine is a dopamine agonist, it is assumed that dopamine antagonists, such as neuroleptics (e.g. phenothiazines, butyrophenones, thioxanthenes) or ...
The NEUPRO Patch delivers the dopamine agonist, rotigotine, through the skin, directly into the bloodstream and releases the medicine 24 hours a day. View Important ...